A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT06954961 · RECRUITING
Trial details
- NCT number
- NCT06954961
- Sponsor
- InventisBio Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2026-11-30
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.